Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 14:2011:143471.
doi: 10.4061/2011/143471.

Role of the kidneys in resistant hypertension

Affiliations

Role of the kidneys in resistant hypertension

Z Khawaja et al. Int J Hypertens. .

Abstract

Resistant hypertension is a failure to achieve goal BP (<140/90 mm Hg for the overall population and <130/80 mm Hg for those with diabetes mellitus or chronic kidney disease) in a patient who adheres to maximum tolerated doses of 3 antihypertensive drugs including a diuretic. The kidneys play a critical role in long-term regulation of blood pressure. Blunted pressure natriuresis, with resultant increase in extracellular fluid volume, is an important cause of resistant hypertension. Activation of the renin-angiotensin-aldosterone system, increased renal sympathetic nervous system activity and increased sodium reabsorption are important renal mechanisms. Successful treatment requires identification and reversal of lifestyle factors or drugs contributing to treatment resistance, diagnosis and appropriate treatment of secondary causes of hypertension, use of effective multidrug regimens and optimization of diuretic therapy. Since inappropriate renal salt retention underlies most cases of drug-resistant hypertension, the therapeutic focus should be on improving salt depleting therapy by assessing and, if necessary, reducing dietary salt intake, optimizing diuretic therapy, and adding a mineralocorticoid antagonist if there are no contraindications.

PubMed Disclaimer

References

    1. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841–845. - PMC - PubMed
    1. Guyton AC, Manning RD, Jr., Hall JE, Norman RA, Jr., Young DB, Pan YJ. The pathogenic role of the kidney. Journal of Cardiovascular Pharmacology. 1984;6(supplement 1):S151–S161. - PubMed
    1. Koomans HA, Roos JC, Boer P. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension. 1982;4(2):190–197. - PubMed
    1. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Archives of Internal Medicine. 2008;168(11):1159–1164. - PMC - PubMed
    1. Brater DC. Anti-inflammatory agents and renal function. Seminars in Arthritis and Rheumatism. 2002;32(3):33–42. - PubMed

LinkOut - more resources